DJIA 17,757.91 0.00 0.00%
NASDAQ 5,013.12 0.00 0.00%
S&P 500 2,077.42 0.00 0.00%
market minute promo

Gilead Sciences (NASDAQ: GILD)

116.01 0.00 (0.00%)

REAL-TIME: Last trade at

Extended Hours: $116.47 $0.46 (0.40%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

GILD $116.01 0.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $118.11
Previous Close $116.01
Daily Range $115.40 - $118.60
52-Week Range $83.32 - $123.37
Market Cap $170.5B
P/E Ratio 13.33
Dividend (Yield) $1.72 (1.5%)
Ex-Dividend Date
Dividend Pay Date
06/12/15
06/29/15
Volume 10,243,831
Average Daily Volume 10,689,724
Current FY EPS $11.04

Sector

Healthcare

Industry

Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/

News & Commentary Rss Feed

3 Common Pitfalls Biotech Investors Need to Learn to Avoid

Here is a look at three common mistakes investors make when buying biotech stocks.

Gilead Sciences- A Rare Undervalued Company In A Frothy Biotech Market

Gilead Submits New Drug Application to U.S. Food and Drug Administration for Single Tablet Regimen f

Gilead Submits New Drug Application to U.S. Food and Drug Administration for Single Tablet Regimen for HIV Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide

What Is Beyond Vision-Loss Blockbuster For Regeneron?

Stock Market News for July 01, 2015 - Market News

10 Best S&P 500 Health Care Stocks

Is Gilead Just the First Biotech Stock to Sink?

Premarket Biotech Digest: Geron's Sharp Gain, Bayer Essure AEs, Juno Moves Higher

Fast Money Picks For July 1

Julian Robertson Discusses Greece Threat, Stocks and Apple

See More GILD News...

GILD's Top Competitors

GILD $116.01 (0.00%)
Current stock: GILD
AMGN $154.99 (0.00%)
Current stock: AMGN
CELG $118.22 (0.00%)
Current stock: CELG
$0.00 (0.00%)
Current stock: